Internal Server Error

BDR Pharmaceuticals - About the company

BDR Pharmaceuticals is a late stage company based in Mumbai (India), founded in 2003. It operates as a Developer and manufacturer of APIs as well as finished products. BDR Pharmaceuticals has raised $94.9M in funding from Multiples Alternate Asset Management, with a current valuation of ₹*****. The company has 347 active competitors, including 22 funded and 88 that have exited. Its top competitors include companies like Bayer, Biological E and Wockhardt.

Company Details

BDR Pharmaceuticals develops and manufactures API. The company also offer new delivery systems and development of new generics. The products are of various therapeutic categories including oncology, critical care, gynecology, respiratory, antidiabetics, neurology, and others. The company has manufacturing facilities certified by WHO-GMP.
Social
X
Phone Number
+91 **********
Registered Address
R S NO 578, 579/A, VILLAGE LUNA, ECP ROAD, TALUKA- PADRA, Padra, Vadodara, Vadodara, Gujarat, India, 391440
Key Metrics
Founded Year
2003
Location
Mumbai, India
Stage
Late Stage
Total Funding
$94.9M in 1 round
Latest Funding Round
Post Money Valuation
₹***** as on Sep 15, 2023
Ranked
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
1,006 as on Sep 30, 2026
Similar Companies
Sign up to download BDR Pharmaceuticals' company profile

BDR Pharmaceuticals's funding and investors

BDR Pharmaceuticals has raised a total funding of $94.9M over 1 round. Its latest funding round was a PE round on Jan 24, 2022 for $*****. 10 investors participated in its latest round. BDR Pharmaceuticals has 11 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of BDR Pharmaceuticals:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 24, 2022
7160509
PE
9377975
7549349
4862749
6286876
lockAccess funding benchmarks and valuations. Sign up today!

BDR Pharmaceuticals' founders and board of directors

Founder? Claim Profile

BDR Pharmaceuticals' Board of Directors

BDR Pharmaceuticals's board has 5 active members. Raheel Shah, Jayesh Shantilal Shah, Dheer Shah and Tejash Shah are part of team and Aravind Manappa Badiger is independent board member.
Here is the list of BDR Pharmaceuticals' board of directors:
Name
Type
Representing
Status
Duration
yyqewhy
Team
-
Past
5y 6m
q{hbcgc
Team
-
Current
2y 9m
hswxypl
Team
-
Current
3y 7m
glvgnzi
Team
-
Past
1y 9m
upaidod
Team
-
Past
4y 7m
Independent board member
-
Current
13y 10m
axnuedr
Independent board member
-
Past
2y 2m
wvfnmud
Independent board member
-
Past
9y 3m
xqqyvzy
Independent board member
-
Past
9y 3m

BDR Pharmaceuticals' employee count trend

BDR Pharmaceuticals has 1,006 employees as of Sep 26. Here is BDR Pharmaceuticals's employee count trend over the years:
Employee count trend for BDR Pharmaceuticals
lockUncover BDR Pharmaceuticals' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

BDR Pharmaceuticals's Competitors and alternates

Top competitors of BDR Pharmaceuticals include Bayer, Biological E and Wockhardt. Here is the list of Top 10 competitors of BDR Pharmaceuticals, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Bayer
Bayer
1863, Leverkusen (Germany), Public
Manufacturer of drugs
-
76/100
2nd
Logo for Biological E
Biological E
1953, Hyderabad (India), Late Stage
Developer of vaccines for treating multiple diseases
$60M
75/100
3rd
Logo for Wockhardt
Wockhardt
1967, Mumbai (India), Public
Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients
-
72/100
4th
Logo for Lupin
Lupin
1968, Mumbai (India), Public
Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients
$6.64M
71/100
5th
Logo for Cipla
Cipla
1935, Mumbai (India), Public
Manufacturer of APIs, generic drugs, and formulation development services
-
69/100
6th
Logo for Emcure
Emcure
1981, Pune (India), Public
Developer, manufacturer, and markets a broad range of pharmaceutical products
$50M
68/100
7th
Logo for Amneal
Amneal
2002, Bridgewater (United States), Public
Manufacturer of generics formulations
-
68/100
8th
Logo for Strides Pharma Science
Strides Pharma Science
1990, Bengaluru (India), Public
Manufacturer of generic pharmaceutical products and various specialty medical formulations
-
68/100
9th
Logo for Aurobindo Pharma
Aurobindo Pharma
1986, Hyderabad (India), Public
Provider of generic biocatalytic products
-
66/100
10th
Logo for Orchid Pharma
Orchid Pharma
1992, Chennai (India), Public
Company offering a suite of pharmaceutical solutions
-
66/100
38th
Logo for BDR Pharmaceuticals
BDR Pharmaceuticals
2003, Mumbai (India), Late Stage
Developer and manufacturer of APIs as well as finished products
$94.9M
56/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on BDR Pharmaceuticals's competitors? Click here to see the top ones

Financials of BDR PharmaceuticalsFY 25 Available

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, the legal entity associated with BDR Pharmaceuticals, generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 2% in the last 1 year.

Financial Statement Summary

Metrics
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
Income Statement
Revenue
3353
7065
2813
6467
3377
Total Sales
8996
9213
4494
8762
5890
Total Expenses
1497
9865
7732
4593
9280
Operating Expenses
1569
8343
1868
4203
8911
Employee Expenses
1290
6234
5879
6795
8501
Marketing Expenses
9461
7993
3646
2145
6215
Operating Income (EBIT)
9028
7910
4299
8107
4521
Interest Expenses
8777
6959
7245
1941
3081
Expenses from other activities
3379
4117
3437
4420
4160
Information Technology Expenses
5680
1347
2143
1825
3984
EBITDA
2527
8110
3810
5591
4351
Taxes
8669
7698
2265
4076
9821
Net Profit
6781
7916
8781
6173
7770
Balance Sheet
Assets
5515
2098
2033
5901
7594
Cash Equivalent
3428
2594
7273
3462
5283
Accounts Receivables
3724
3035
9497
3015
5001
Inventory
7614
3897
3501
2295
9441
Liabilities
9011
4111
9427
6964
6073
Total Debt
7131
8186
6899
9003
2472
Accounts Payable
6929
6083
1682
5604
8035
Equities
3587
5516
5152
9099
4075
Cashflow Statement
Cash from Operating activities
6316
7591
2135
6881
8721
Cash from Investing activities
1854
2266
2348
4357
8867
Net cash from Financing activities
4011
9896
3290
4765
8664

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Gain deeper financial insights
of this entity
$10.99$2.53(excl. taxes)
Download Sample Report
What documents will you get?
  • Financial Summary & Charts
  • Detailed Income Statement, Balance Sheet, Cashflow Statement
  • Profitability Ratios, Liquidity Ratios, Growth Rates

BDR Pharmaceuticals's Latest cap tables and shareholding

Founders own 0.91%, Funds (largest shareholder) own 8.38%, Enterprises own 1.22% and Angels own 0.54%. The net worth of BDR Pharmaceuticals's founders is INR 67.2Cr as of Sep 15, 2023. The cap table displayed below is for BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED which is the legal entity associated with BDR Pharmaceuticals.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
0.91%
67.2Cr
0
0
0
0
Fund
8.38%
620Cr
9649119
6025279
9403329
5814604
6581876
6140524
7146301
9020104
6461817
6926320
Enterprise
1.22%
90Cr
8
3
4
7
Angel
0.54%
40Cr
0
0
0
0
Other People
88.96%
6,580Cr
3400320
8293113
4076755
1627814
Total
100.00%
7,400Cr
2984489
3642233
6636093
1386830
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
Gain deeper insights into
shareholding pattern of this entity
$9.99$4.23(excl. taxes)
Download Sample Files
What documents will you get?
  • Latest Shareholding Summary - Ownership breakdown across founders, investors, and other stakeholders
  • Round-by-Round Cap Tables - Evolution of shareholding across funding rounds
  • Year-on-Year Cap Tables - Dilution trends over time

BDR Pharmaceuticals's Investments and acquisitions

BDR Pharmaceuticals has made no investments or acquisitions yet.

Reports related to BDR Pharmaceuticals

Here is the latest report on BDR Pharmaceuticals's geography:

News related to BDR Pharmaceuticals

lockFilter this list
Media has covered BDR Pharmaceuticals for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
BDR Pharma Launches XATRONEM-AV to Combat Antimicrobial ResistanceIndiaMedToday•Jun 25, 2026•BDR Pharmaceuticals
•
CDSCO Panel Clears BDR Pharma's Abiraterone Oral Suspension, Seeks Phase IV TrialMedical Dialogues•Oct 15, 2025•BDR Pharmaceuticals
•
BDR Pharma Targets 2027 for IPO Launch, Seeks US AcquisitionsMoneycontrol•Apr 29, 2025•BDR Pharmaceuticals
•
•
Procaps Group and BDR sign agreement for oncology moleculesPharmaceutical Business Review•Sep 08, 2023•Procaps Group, BDR Pharmaceuticals
•
BDR Pharma launches Dalbonova InjectionIndiaMedToday•Aug 31, 2023•BDR Pharmaceuticals
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about BDR Pharmaceuticals

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford